278 related articles for article (PubMed ID: 7004690)
1. Drug-induced aplastic anaemia: clinical aspects.
Heimpel H; Heit W
Clin Haematol; 1980 Oct; 9(3):641-62. PubMed ID: 7004690
[No Abstract] [Full Text] [Related]
2. Aplastic anaemia. II. Drug-induced aplastic anaemia.
Böttiger LE; Westerholm B
Acta Med Scand; 1972 Oct; 192(4):319-21. PubMed ID: 5081069
[No Abstract] [Full Text] [Related]
3. Aplastic anaemia. I. Incidence and aetiology.
Böttiger LE; Westerholm B
Acta Med Scand; 1972 Oct; 192(4):315-8. PubMed ID: 5081068
[No Abstract] [Full Text] [Related]
4. Phenylbutazone, oxyphenbutazone and aplastic anaemia.
Böttiger LE
Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472
[No Abstract] [Full Text] [Related]
5. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II.
Chaplin S
Adverse Drug React Acute Poisoning Rev; 1986; 5(3):181-96. PubMed ID: 3538824
[No Abstract] [Full Text] [Related]
6. A prospective study of chloramphenicol induced aplastic anaemia in Nigerians.
Durosinmi MA; Ajayi AA
Trop Geogr Med; 1993; 45(4):159-61. PubMed ID: 8236465
[TBL] [Abstract][Full Text] [Related]
7. Experimental drug-induced aplastic anaemia.
Haak HL
Clin Haematol; 1980 Oct; 9(3):621-39. PubMed ID: 7004689
[No Abstract] [Full Text] [Related]
8. [Idiopathic and drug-induced acquired aplastic anemia].
Keiser G; Walder HR
Schweiz Med Wochenschr; 1970 Apr; 100(16):697-702. PubMed ID: 5524822
[No Abstract] [Full Text] [Related]
9. Editorial: Drug-induced aplastic anaemia.
Lancet; 1974 Feb; 1(7851):251-2. PubMed ID: 4130254
[No Abstract] [Full Text] [Related]
10. [The relationship between drug exposure and acquired aplastic anemia].
Lin GW
Zhonghua Nei Ke Za Zhi; 1986 Jan; 25(1):3-6, 62. PubMed ID: 3731952
[No Abstract] [Full Text] [Related]
11. Drug-induced aplastic anaemia in Sweden with special reference to chloramphenicol.
Böttiger LE
Postgrad Med J; 1974 Oct; 50 Suppl 5():127-31. PubMed ID: 4470806
[No Abstract] [Full Text] [Related]
12. In vitro evidence of drug action in aplastic anemia.
Vincent PC
Blut; 1984 Jul; 49(1):3-12. PubMed ID: 6378281
[No Abstract] [Full Text] [Related]
13. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I.
Chaplin S
Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881
[No Abstract] [Full Text] [Related]
14. Aplastic anaemia. 3. Aplastic anaemia and infectious hepatitis.
Böttiger LE; Westerholm B
Acta Med Scand; 1972 Oct; 192(4):323-6. PubMed ID: 5081070
[No Abstract] [Full Text] [Related]
15. [Study of the pathogenic factors of aplastic anemia].
Zhang RF; Lin GF; Xu LP
Zhonghua Nei Ke Za Zhi; 1986 Jan; 25(1):13-6, 62-3. PubMed ID: 3731950
[No Abstract] [Full Text] [Related]
16. Follow-up studies in chloramphenicol-induced aplastic anaemia.
Hellriegel KP; Gross R
Postgrad Med J; 1974 Oct; 50 Suppl 5():136-42. PubMed ID: 4470809
[No Abstract] [Full Text] [Related]
17. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
Inman WH
Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632
[TBL] [Abstract][Full Text] [Related]
18. [Etiology and pathogenesis of panmyelopathies].
Hartwich G; Schwabel HJ
Med Klin; 1973 Jun; 68(23):757-61. PubMed ID: 4579458
[No Abstract] [Full Text] [Related]
19. Aplastic anaemia following chloramphenicol therapy in Hamburg and surrounding districts.
Hausmann K; Skrandies G
Postgrad Med J; 1974 Oct; 50 Suppl 5(581):131-6. PubMed ID: 4470808
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutazone, oxyphenbutazone labeling revised.
FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
